Authors Corporeau C, Huvet A, Pichereau V, Delisle L, Quéré C, Dubreuil C, Artigaud S, Brenner C, Meyenberg Cunha-De Padua M, Mazure N
Medecine sciences : M/S May 2019
PGC1α Inhibits Polyamine Synthesis to Suppress Prostate Cancer Aggressiveness.Authors Kaminski L, Torrino S, Dufies M, Djabari Z, Haider R, Roustan FR, Jaune E, Laurent K, Nottet N, Michiels JF, Gesson M, Rocchi S, Mazure NM, Durand M, Tanti JF, Ambrosetti D, Clavel S, Ben-Sahra I, Bost F
Cancer research May 2019
UBTD1 is a mechano-regulator controlling cancer aggressiveness.Authors Torrino S, Roustan FR, Kaminski L, Bertero T, Pisano S, Ambrosetti D, Dufies M, Uhler JP, Lemichez E, Mettouchi A, Gesson M, Laurent K, Gaggioli C, Michiels JF, Lamaze C, Bost F, Clavel S
EMBO reports Apr 2019
Primary Cilium in Cancer Hallmarks.Authors Fabbri L, Bost F, Mazure NM
International journal of molecular sciences Mar 2019
Primary Cilium in Cancer Hallmarks.Authors Fabbri L, Bost F, Mazure NM
International journal of molecular sciences Mar 2019
Editorial: Metformin: Beyond Diabetes.Authors Bost F, Rena G, Viollet B
Frontiers in endocrinology Jan 2019
Hypoxia protects against the cell death triggered by oxovanadium-galactomannan complexes in HepG2 cells.Authors Meyenberg Cunha-de Padua M, Noleto GR, de Oliveira Petkowicz CL, Cadena SMSC, Bost F, Pouysségur J, Mazure NM
Cellular & molecular biology letters Jan 2019
The metabolic modulator PGC-1α in cancer.Authors Bost F, Kaminski L
American journal of cancer research Jan 2019
Protein N-glycosylation alteration and glycolysis inhibition both contribute to the antiproliferative action of 2-deoxyglucose in breast cancer cells.Authors Berthe A, Zaffino M, Muller C, Foulquier F, Houdou M, Schulz C, Bost F, De Fay E, Mazerbourg S, Flament S
Breast cancer research and treatment Oct 2018
Hypoxic-induced truncation of voltage-dependent anion channel 1 is mediated by both asparagine endopeptidase and calpain 1 activities.Authors Pahima H, Reina S, Tadmor N, Dadon-Klein D, Shteinfer-Kuzmine A, Mazure NM, De Pinto V, Shoshan-Barmatz V
Oncotarget Feb 2018